Analysts Are Bullish on These Healthcare Stocks: Allurion Technologies (ALUR), Savara (SVRA)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Allurion Technologies (ALUR – Research Report), ...
JP Morgan Survey: 90% Of Endocrinologists Are Aware Of Crinetics' Atumelnant Data
JP Morgan's survey of endocrinologists finds strong awareness of Crinetics' atumelnant, with positive efficacy impressions.
Wall Street Analysts Are Bullish on Top Healthcare Picks
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on KalVista Pharmaceuticals (KALV – Research ...
Crinetics Pharmaceuticals Analyst Sees Around 70% Upside For Stock, Cites More Investor Interest In Endocrinology
Stifel initiates coverage on CRNX, a clinical-stage pharmaceutical company focused on endocrine diseases and tumors.
Fintel on MSN2d
Stifel Initiates Coverage of Crinetics Pharmaceuticals (CRNX) with Buy Recommendation
Fintel reports that on March 25, 2025, Stifel initiated coverage of Crinetics Pharmaceuticals (NasdaqGS:CRNX) with a Buy recommendation. Analyst Price Forecast Suggests 114.68% Upside As of March 19, ...
Zurcher Kantonalbank Zurich Cantonalbank Acquires 2,970 Shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX)
Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Free ...